Inventiva S.A. Operating Income 2011-2026 | IVA

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Inventiva S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-52.1 M	-29.7 M	-30.3 M	-32.9 M	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
-29.7 M	-52.1 M	-36.3 M

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	-36 M	$ 2.19	7.88 %	$ 123 M	China
Acorda Therapeutics ACOR	-265 M	-	-24.86 %	$ 820 K	USA
BioLineRx Ltd. BLRX	-24.8 M	$ 3.03	2.35 %	$ 908 M	Israel
BioNTech SE BNTX	15.3 B	$ 117.93	-0.46 %	$ 27.2 B	Germany
Aeterna Zentaris AEZS	-8.67 M	-	5.93 %	$ 314 M	Canada
BioXcel Therapeutics BTAI	-67.2 M	$ 1.83	0.83 %	$ 4.64 M	USA
AgeX Therapeutics AGE	-9.89 M	-	-10.17 %	$ 12.2 K	USA
Burford Capital Limited BUR	242 M	$ 9.64	-2.33 %	$ 1.58 B	Britain
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Can-Fite BioPharma Ltd. CANF	-8.13 M	$ 4.23	1.68 %	$ 9.2 B	Israel
Aeglea BioTherapeutics AGLE	-209 M	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	205 M	$ 26.09	-0.21 %	$ 1.26 B	USA
Midatech Pharma plc MTP	-7 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
Coherus BioSciences CHRS	-203 M	$ 2.03	27.67 %	$ 191 M	USA
Aravive ARAV	-70.8 M	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	-101 M	-	-	$ 269 M	USA
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	10.2 M	-	1083.1 %	$ 745 M	USA
Applied Molecular Transport AMTI	-127 M	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	-452 M	$ 230.76	0.92 %	$ 5 B	Danmark
ARCA biopharma ABIO	-88.1 M	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	-7.83 M	$ 2.72	0.37 %	$ 17.1 M	USA
Corcept Therapeutics Incorporated CORT	137 M	$ 42.02	1.74 %	$ 4.34 B	USA
Acasti Pharma ACST	-16.7 M	-	4.01 %	$ 150 M	Canada
Catalyst Pharmaceuticals CPRX	195 M	$ 24.23	-0.9 %	$ 2.87 B	USA
Arrowhead Pharmaceuticals ARWR	98.3 M	$ 70.82	1.77 %	$ 9.47 B	USA
Brickell Biotech BBI	-6.36 M	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	-568 M	-	0.49 %	$ 251 B	Cayman-islands
Champions Oncology CSBR	4.55 M	$ 6.9	-0.43 %	$ 94.3 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	-140 M	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	-11.5 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	-123 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	-412 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	-24.6 M	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	-27 M	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	-58.1 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-65.4 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-33.3 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	7.04 B	$ 171.66	-1.23 %	$ 25 B	USA
Bio-Path Holdings BPTH	-15.8 M	-	-	$ 100 K	USA
BioVie BIVI	-18.1 M	$ 1.26	0.79 %	$ 1.86 M	USA
Baudax Bio BXRX	-56.8 M	-	0.59 %	$ 63 K	USA